Hemiplegia Clinical Trials 2023

Hemiplegia Clinical Trials 2023

Hemiplegia research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in hemiplegia clinical trials today.

Trials for Ischemic Stroke Patients

Trials for Hemiplegic Shoulder Subluxation Patients

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to hemiplegia

What are the top hospitals conducting hemiplegia research?

When it comes to advancing treatments and therapies for hemiplegia, several top hospitals are leading the way. In Cleveland, MetroHealth Medical Center stands out with its dedication to this condition. With two ongoing clinical trials and a total of six completed trials since their first recorded investigation in 2005, MetroHealth is at the forefront of hemiplegia research. Another hospital making strides in Philadelphia is Penn Medicine Rittenhouse, which currently has two active hemiplegia trials and has conducted three previous studies since their inaugural trial in 2014.

In addition to these institutions, Cleveland's Louis Stokes Cleveland Veterans Affairs Medical Center plays an essential role by actively participating in one current hemiplegia trial while having accomplished one successful study thus far; their groundbreaking work began just recently in 2023. Meanwhile, Mercy Living Independently for Elders (L.I.F.E) - West Philadelphia is contributing significantly with one ongoing clinical trial focused on hemiplegia patients as well as conducting a single successful investigation since recording their trailblazing efforts starting from2022.

Furthermore joining this list is the Medical University of South carolina located in Charleston where they have dedicated themselves to furthering our understanding ofhemiplegic conditions through their ongoing effortsto conduct cutting-edge therapy facilitated byone recent exploration started backin 2022

These esteemed hospitals are not only providing hope but also paving the way for innovative advancements that can potentially transform the lives of individuals affected by hemiplegia. Together, they showcase how collaboration and commitment within medical communities can make significant strides towards improving treatment options for those living with this condition.

Which are the best cities for hemiplegia clinical trials?

Cleveland, Ohio; Philadelphia, Pennsylvania; White Plains and Valhalla in New york; and Loma Linda, California are prominent cities for hemiplegia clinical trials. These locations offer a range of studies investigating various treatments and interventions for individuals with hemiplegia. Some trials focus on innovative approaches like implantation, controller development, and evaluation in Cleveland; robot-assisted therapy using Rehab CARES system in Philadelphia; seated exercise and active transcranial direct current stimulation in White Plains; bimanual hand therapy and tdcs plus robotic training in Valhalla. Additionally, Loma Linda explores the Integrated Cueing Protocol among other techniques to improve outcomes for those living with hemiplegia.

Which are the top treatments for hemiplegia being explored in clinical trials?

In the realm of hemiplegia treatment, several promising avenues are being explored through clinical trials. One notable approach is Robot-Assisted Therapy with the Rehab CARES system, currently under investigation in one active trial dedicated to hemiplegia. Another intriguing option is transcutaneous auricular vagus nerve stimulation, also undergoing examination in one ongoing trial specifically focused on hemiplegia cases. Additionally, seated exercise has shown promise and is being evaluated in another active trial for individuals dealing with this condition. These innovative treatments offer hope for improved outcomes and quality of life for patients grappling with hemiplegia.

What are the most recent clinical trials for hemiplegia?

Recent clinical trials have provided promising advancements in the treatment of hemiplegia, a condition characterized by paralysis or weakness on one side of the body. One notable trial investigated the efficacy of a new drug specifically designed to alleviate symptoms and improve motor function in individuals with hemiplegia. Another study explored the benefits of combining physical therapy with virtual reality technology, enhancing rehabilitation outcomes for patients. With these groundbreaking trials offering hope for those living with hemiplegia, there is renewed optimism for improved quality of life and enhanced functional abilities.

What hemiplegia clinical trials were recently completed?

Several clinical trials focusing on hemiplegia, a condition characterized by paralysis of one side of the body, have recently concluded. These trials represent crucial steps towards advancing treatment options for individuals affected by this debilitating condition.